V H Springett. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Aminosalicylic Acids/administration & dosageAminosalicylic Acids/therapeutic useCapreomycin/adverse effectsCapreomycin/therapeutic useEthambutol/administration & dosageEthambutol/therapeutic useEthionamide/adverse effectsEthionamide/therapeutic useHumansIsoniazid/administration & dosageIsoniazid/therapeutic useProthionamide/adverse effectsProthionamide/therapeutic usePyrazinamide/adverse effectsPyrazinamide/therapeutic useRifampin/administration & dosageRifampin/therapeutic useStreptomycin/administration & dosageStreptomycin/therapeutic useThioacetazone/therapeutic useTuberculosis/drug therapyTuberculosis/therapy
Substances： See more » Aminosalicylic AcidsCapreomycinPyrazinamideProthionamideEthambutolThioacetazoneEthionamideIsoniazidRifampinStreptomycin
Year: 1975 PMID： 53832
Source DB: PubMed Journal: Practitioner ISSN： 0032-6518